LYNX Lynx Therapeutics, Inc
$15.71
Lynx Therapeutics, Inc (LYNX) SEC Filings
Everything LYNX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 8-K MATERIAL_AGREEMENT | View filing | |
| 8-K EXECUTIVE_CHANGE | View filing | |
| 8-K GOVERNANCE_CHANGE | View filing | |
| 8-K OTHER_EVENT | View filing | |
| 8-K CAPITAL_RAISE | View filing | |
| 8-K OTHER | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.